Citation Tools
Clinical/translational cancer immunotherapy
Original research
Comparison of iRECIST versus RECIST V.1.1 in patients treated with an anti-PD-1 or PD-L1 antibody: pooled FDA analysis
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Comparison of iRECIST versus RECIST V.1.1 in patients treated with an anti-PD-1 or PD-L1 antibody: pooled FDA analysis